ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

A Novel Potent and Selective GCN2 Inhibitor, APL-4098, Has Antileukemic Activity through Dysregulation of Mitochondrial Function.

Mónica Román-Trufero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.